OMCL - Background and mission
additional information
- REVISED Terms of Reference for the GEON of the CoE: PA/PH/OMCL (07) 79 R39CORR
- Annex 1 to the GEON Terms of Reference: Definition, role and status of OMCLs of the GEON (PA/PH/OMCL (07) 89 R15)
- REVISED Annex 2 to the GEON Terms of Reference: Factors for determining OMCL status within the GEON (PA/PH/OMCL (07) 90 R12)
- REVISED Annex 3 to the GEON Terms of Reference: List of GEON Members (PA/PH/OMCL (09) 45 R35)
- Annex 4 to the GEON Terms of Reference: Questionnaire to query the OMCL status of present and future members of the GEON (PA/PH/OMCL (08) 04 R22)
- Annex 5 to the GEON Terms of Reference: Maintenance of Membership to the GEON (PA/PH/OMCL (10) 93 R10)
- Annex 6 to the GEON Terms of Reference: Application for new membership to the GEON (PA/PH/OMCL (09) 83 8R)
- Annex 7 to the GEON Terms of Reference: Mutual Recognition of Test Results (PA/PH/OMCL (16) 49 R2)
- Annex 8 to the GEON Terms of Reference: Policy in case of exceptional voting (PA/PH/OMCL (15) 99 R3)
Video
Discover how Official Medicines Control Laboratories contribute to protect your health in Europe and beyond
Recent updates
Previous press releases
- OMCL Annual Meeting 2022: European Strategies for Work Sharing and Collaboration in Testing of Medicines - June 2022
- OMCL Annual Meeting 2021: European Quality Control Programmes and Strategies for Medicines - September 2021
- Annual OMCL Network meeting focuses on role of OMCLs during the COVID-19 pandemic - May 2020
- OMCL Network discusses strategy and reviews past year’s activity at annual meeting - June 2019
- OMCLs discuss Brexit and updates to medicines’ testing methods at annual meeting - May 2018